Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_assertion type Assertion NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_head.
- NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_assertion wasGeneratedBy ECO_0000203 NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_provenance.
- NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_assertion wasDerivedFrom befree-20140225 NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_provenance.
- NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_assertion SIO_000772 23585456 NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_provenance.
- NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_assertion evidence source_evidence_literature NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_provenance.
- NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278853.RAZV-FoPaGp4EV3URmRxDxVnd0YNBE6s6qVieY7aetbZM130_provenance.